AS
Ameera Sushil Shah
About Ameera Sushil Shah
Data last updated:
Ameera Sushil Shah has 23 years in corporate governance. Holds Director and Whole-Time Director roles. Currently with 8 companies, including Torrent Pharmaceuticals Ltd and Marico Kaya Enterprises Limited. Formerly with 30 companies, such as Acc Limited and Metropolis Foundation. Engaged in General Business, Healthcare and more. Contributes to corporate operations. The 6 current companies with reported revenue have a combined latest revenue of ₹15,271 Cr; the largest is Torrent Pharmaceuticals Ltd at ₹13,886 Cr (FY 2026).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 02 Aug 2018 | 1972 | ₹13,886 Cr (FY 2026) | Active | |
| Whole-Time Director | 06 May 2008 | 2000 | ₹1,346 Cr (FY 2025) | Active | |
| Director | 15 May 2023 | 2011 | ₹25.51 Cr (FY 2025) | Active | |
| Designated Partner | 03 Nov 2015 | 2015 | ₹13.02 Cr (FY 2023) | Active | |
| Director | 05 Jul 2023 | 2013 | ₹33.5 Lakh (FY 2016) | Active | |
| Director | 08 Feb 2018 | 2018 | ₹84,620 (FY 2025) | Active | |
| Director | 15 Sep 2025 | 2025 | – | Active | |
| Designated Partner | 18 Feb 2025 | 2025 | – | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 03 Dec 2022 | 1936 | ₹22,835 Cr (FY 2025) | Active | |
| Director | 03 May 2024 | 2024 | – | Active | |
| Director | 30 Nov 2011 | 1992 | ₹1.35 Cr (FY 2025) | Active | |
| Additional Director | 02 Mar 2009 | 2001 | ₹1.4 Lakh (FY 2018) | Amalgamated | |
| Director | 21 Feb 2012 | 2009 | ₹25.47 Cr (FY 2021) | Amalgamated | |
| Director | 28 Aug 2008 | 2004 | ₹294 Cr (FY 2023) | Active | |
| Director | 05 Nov 2007 | 2007 | ₹13.92 Cr (FY 2018) | Amalgamated | |
| Director | 29 Dec 2004 | 2004 | ₹7.8 Lakh (FY 2016) | Strike Off | |
| Director | 19 Jun 2014 | 2013 | – | Amalgamated | |
| Director | 23 Dec 2009 | 2009 | – | Strike Off | |
| Director | 03 Apr 2008 | 2005 | ₹42.82 Cr (FY 2021) | Amalgamated | |
| Director | 21 Jul 2003 | 2003 | – | Amalgamated | |
| Director | 08 Jan 2008 | 2008 | ₹38.77 Cr (FY 2021) | Amalgamated | |
| Director | 09 Nov 2009 | 1983 | ₹45.88 Cr (FY 2021) | Amalgamated | |
| Whole-Time Director | 13 May 2006 | 2003 | – | Amalgamated | |
| Director | 18 Jan 2003 | 2000 | – | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ameera Sushil Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ameera Sushil Shah
Ameera Sushil Shah has 23 years in corporate governance. Holds Director and Whole-Time Director roles. Currently with 8 companies, including Torrent Pharmaceuticals Ltd and Marico Kaya Enterprises Limited. Formerly with 30 companies, such as Acc Limited and Metropolis Foundation. Engaged in General Business, Healthcare and more. Contributes to corporate operations. The 6 current companies with reported revenue have a combined latest revenue of ₹15,271 Cr; the largest is Torrent Pharmaceuticals Ltd at ₹13,886 Cr (FY 2026).
Ameera Sushil Shah is associated with 8 companies as Director and Whole-Time Director, including Torrent Pharmaceuticals Ltd (₹13,886 Cr), Metropolis Healthcare Limited (₹1,346 Cr), Centralab Healthcare Services Private Limited (₹25.51 Cr).
Ameera Sushil Shah has expertise in General Business, Healthcare and other sectors.
Ameera Sushil Shah has 23 years in corporate governance.
By reported revenue, the largest current company of Ameera Sushil Shah is Torrent Pharmaceuticals Ltd, with revenue of ₹13,886 Cr (FY 2026).
The 6 current companies of Ameera Sushil Shah that report revenue have a combined latest revenue of ₹15,271 Cr.
Ameera Sushil Shah currently holds positions at 8 companies; the 5 largest by reported revenue are Torrent Pharmaceuticals Ltd (₹13,886 Cr), Metropolis Healthcare Limited (₹1,346 Cr), Centralab Healthcare Services Private Limited (₹25.51 Cr), Metz Advisory Llp (₹13.02 Cr), Metropolis Health Products Retail Private Limited (₹33.5 Lakh).